Acute laryngitis

Summary

Acute laryngitis (MONDO:0004777) is a disease and 6 clinical trials. A subtype of laryngitis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 6

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	acute laryngitis
Mondo ID	MONDO:0004777
DOID	DOID:9396
ICD-10-CM	J04.0
ICD-11	1180710837
NCIT	C26688
SNOMED CT	6655004
UMLS	C0001327
MedGen	1317
Is cancer (heuristic)	no

Also known as: laryngitis · laryngitis, acute

Disease family

This is a subtype of laryngitis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › respiratory system disorder › upper respiratory tract disorder › laryngeal disorder › laryngitis › acute laryngitis

Related subtypes (3): laryngotracheitis, chronic laryngitis, laryngeal tuberculosis

Subtypes (3): viral laryngitis, croup, acute epiglottitis

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 6.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	6

Top trials by phase / activity

NCT	Phase	Status	Title
NCT06023550	Not specified	RECRUITING	Complicated Infections in Otorhinolaryngology
NCT07359287	Not specified	RECRUITING	Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care
NCT00517114	Not specified	COMPLETED	Prospective Double-blinded Randomized Controlled Trial of 12-weeks High Dose Rabeprazole (Pariet) in the Treatment of Reflux Laryngitis in Chinese Patients
NCT02048449	Not specified	COMPLETED	Inter-rater Reliability of the Reflux Finding Score Among Gastroenterologists
NCT02160912	Not specified	COMPLETED	Non Interventional Study (NIS) Regarding the Application of Ectoin Mund- & Rachenspray in Patients With Acute Laryngitis and/or Acute Pharyngitis
NCT04771221	Not specified	COMPLETED	Method of Early Diagnosis of Laryngopharyngeal Reflux